Premium
Clinical applications of MS‐based protein quantification
Author(s) -
Sabbagh Bassel,
Mindt Sonani,
Neumaier Michael,
Findeisen Peter
Publication year - 2016
Publication title -
proteomics – clinical applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 54
eISSN - 1862-8354
pISSN - 1862-8346
DOI - 10.1002/prca.201500116
Subject(s) - medicine , therapeutic drug monitoring , drug , computational biology , intensive care medicine , pharmacology , biology
Mass spectrometry‐based assays are increasingly important in clinical laboratory medicine and nowadays are already commonly used in several areas of routine diagnostics. These include therapeutic drug monitoring, toxicology, endocrinology, pediatrics, and microbiology. Accordingly, some of the most common analyses are therapeutic drug monitoring of immunosuppressants, vitamin D, steroids, newborn screening, and bacterial identification. However, MS‐based quantification of peptides and proteins for routine diagnostic use is rather rare up to now despite excellent analytical specificity and good sensitivity. Here, we want to give an overview over current fit‐for‐purpose assays for MS‐based protein quantification. Advantages as well as challenges of this approach will be discussed with focus on feasibility for routine diagnostic use.